MetLife Investment Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
181,262
+60,285
| +50% | +$72.3K | ﹤0.01% | 2145 |
|
|
2025
Q1 | $131K | Sell |
120,977
-62,405
| -34% | -$67.4K | ﹤0.01% | 2403 |
|
|
2024
Q4 | $321K | Buy |
183,382
+40,057
| +28% | +$70.1K | ﹤0.01% | 2033 |
|
|
2024
Q3 | $277K | Buy |
143,325
+66,410
| +86% | +$128K | ﹤0.01% | 2119 |
|
|
2024
Q2 | $136K | Buy |
+76,915
| New | +$136K | ﹤0.01% | 2455 |
|
|
2022
Q2 | – | Sell |
-35,462
| Closed | -$127K | – | 2887 |
|
|
2022
Q1 | $127K | Buy |
35,462
+26,153
| +281% | +$93.9K | ﹤0.01% | 2574 |
|
|
2021
Q4 | $36.5K | Sell |
9,309
-20,592
| -69% | -$80.7K | ﹤0.01% | 2474 |
|
|
2021
Q3 | $197K | Hold |
29,901
| – | – | ﹤0.01% | 2113 |
|
|
2021
Q2 | $184K | Buy |
29,901
+23,924
| +400% | +$147K | ﹤0.01% | 2220 |
|
|
2021
Q1 | $27K | Sell |
5,977
-26,759
| -82% | -$121K | ﹤0.01% | 2298 |
|
|
2020
Q4 | $196K | Sell |
32,736
-3,119
| -9% | -$18.7K | ﹤0.01% | 1995 |
|
|
2020
Q3 | $266K | Hold |
35,855
| – | – | ﹤0.01% | 1686 |
|
|
2020
Q2 | $144K | Buy |
+35,855
| New | +$144K | ﹤0.01% | 2075 |
|
|
2019
Q4 | – | Sell |
-32,475
| Closed | -$150K | – | 2317 |
|
|
2019
Q3 | $150K | Hold |
32,475
| – | – | ﹤0.01% | 2101 |
|
|
2019
Q2 | $400K | Buy |
32,475
+16,371
| +102% | +$202K | ﹤0.01% | 1614 |
|
|
2019
Q1 | $214K | Buy |
+16,104
| New | +$214K | ﹤0.01% | 1948 |
|
|
2018
Q2 | – | Sell |
-20,596
| Closed | -$120K | – | 2200 |
|
|
2018
Q1 | $120K | Hold |
20,596
| – | – | ﹤0.01% | 2128 |
|
|
2017
Q4 | $121K | Buy |
+20,596
| New | +$121K | ﹤0.01% | 2171 |
|